TeraGrid Logo
Learn About the TeraGridTeraGrid NewsEducation & TrainingScience GatewaysUser Support & Documentation

Section site map: News

News

News

Fighting the flu

New insight into proton movement could help researchers develop additional anti-flu drugs.

Download a pdf of the print version.

The M2 channel with the proton-conducting water wire disrupted by the presence of the anti-flu drug amantadine. The helices of the M2 channel (blue), the proton-gating His37 residues (mauve), and the proton-blocking amantadine molecule (orange) are depicted. The lipid bi-layer membrane is not shown so that the channel can be seen more clearly. Image courtesy of Hanning Chen.

The symptoms appear suddenly and often-a continuous fever, shaking chills, body aches, muscle pain, fatigue, loss of appetite, and nausea. Most of us have suffered from the viral illness influenza, commonly known as the flu. In most cases, home treatment is all that is needed for recovery, but sometimes the flu can lead to life-threatening complications, such as bacterial pneumonia.

University of Utah chemistry professor Gregory Voth and his research team recently published a study on the uniqueness of the influenza A M2 channel and its effect on proton transport in the virus. The M2 channel is a trans-membrane, four-helix channel believed to play a key role in the viral life cycle by allowing protons to flow though it. This transport of protons facilitates the viral replication process in a host cell. In terms of basic research, the M2 channel is of considerable relevance to drug design and virology, the study of biological viruses and virus-like agents. In biology, many such channels with different roles exist, but the M2 channel exhibits unique pH-gated behavior as opposed to the voltage-gated behavior of many other proton channels.

Voth and his research team used TACC's Lonestar and IU's Big Red systems to carry out the research. They also used systems at NCSA to develop a multi-state empirical valence bond approach (MS-EVB), which allows explicit proton transport to be simulated using molecular dynamics simulations.

According to Voth, the challenge of understanding proton transport requires computational simulations benchmarked against experimental results. "I'm a huge fan of the TeraGrid," says Voth, who is the second-largest TeraGrid user. "The TeraGrid cluster systems are phenomenally useful. There isn't any doubt that these resources have enabled our research."

The calculation of proton transport pathways requires a novel computational methodology combined with extensive simulation over many fast processors to achieve meaningful statistical convergence. This makes proton transport one of the most challenging molecular processes to study through computer simulation for two reasons: 1) it involves a chemical bonding topology that is continuously formed and broken because of the ability of protons to shuttle through water molecules and certain amino acids, and 2) the excess proton charge is delocalized and constantly changing its location.

The M2 channel research team. Top row, left to right: Hanning Chen, Matt K. Petersen, Gregory A. Voth, C. Mark Maupin. Bottom row, left to right: Jiancong Xu, Jessica M. J. Swanson. Image courtesy of the Center for Biophysical Modeling and Simulation, University of Utah.

Despite these challenges, Voth says that the computer simulations made possible by the TeraGrid play a critical role in determining the mechanism of proton transport. "One of the hallmarks of our research is that we avoid cutting corners on the accurate modeling to the extent possible," Voth says. "We set very high standards and constantly refine and validate the model. We also keep pushing the frontiers of what we're doing in terms of its complexity and challenge."

Using Lonestar and Big Red, Voth and his research group have solved part of the proton transport mystery. Their study explains how the M2 channel operates as a proton conductor in responding to the acidic conditions on either side of the cell membrane. The study also explains how the anti-flu drug amantadine blocks the channel and causes it to shut down.

As new experimental measurements of proton conductance and the structure of the full M2 protein (not just the trans-membrane channel) become available, Voth's next step is to study the strains of M2 that do not bind amantadine to see if other compounds might be effective anti-flu drugs.



More information

http://www.cbms.utah.edu/

More News Releases

TeraGrid logo
NSF logo

The TeraGrid project is funded by the National Science Foundation and includes 11 partners:
Indiana, LONI, NCAR, NCSA, NICS, ORNL, PSC, Purdue, SDSC, TACC and UC/ANL.

Please email help@teragrid.org with questions or comments or out the convenient online feedback form.

This site is XHTML 1.0 Transitional, CSS, & Section 508 compliant.